Recognizing Frailty in Older-Person Care: Why It Matters for Quality, Safety and Care Planning in Viet Nam
AGE-FRIENDLY CARE QUALITY
Recognizing Frailty in Older-Person Care: Why It Matters for Quality, Safety and Care Planning in Viet Nam
AGE-FRIENDLY CARE QUALITY
Last reviewed: October 2026
Two older people can be the same age, have similar diagnoses and receive similar treatment, yet respond very differently to the same illness or hospitalization. One may recover quickly, while the other loses mobility, becomes confused, needs substantially more help at home or takes months to return to their previous level of function. Frailty helps explain part of that difference.
Frailty is not simply another disease diagnosis. It describes vulnerability that emerges when physiological reserve and the ability to recover from stress are reduced. A stressor may be substantial, such as surgery or severe infection, but it can also be relatively modest: a medication change, a minor infection, several days of reduced activity, a fall or disruption of usual support. When reserve is limited, an event that causes only temporary disruption for one person may lead to major functional decline in another.
WHO’s Clinical Consortium on Healthy Ageing has described frailty in terms of reduced physiological reserve, dysregulation across multiple systems and greater vulnerability to adverse outcomes when a person encounters a stressor. A 2026 consensus document from the CIBERFES Working Group, involving 25 research centers focused on frailty and healthy aging, similarly emphasizes declining functional reserve, impaired homeostasis and reduced capacity to respond to stressors. Importantly, that consensus also notes that the field still lacks a universally accepted definition and a single gold-standard assessment tool.
For Viet Nam, frailty deserves increasing attention not because every older person should acquire another label, but because recognizing vulnerability may help health and care organizations make safer, more individualized decisions before an apparently manageable problem becomes a major loss of function.
Frailty is not the same thing as old age
Frailty becomes more common with advancing age, but chronological age and frailty are not interchangeable. An 85-year-old may remain active, independent and resilient, while someone substantially younger may have limited reserve because of illness, nutritional problems, inactivity or other factors. Using age alone as a proxy for frailty can therefore obscure important differences between people.
Frailty is also distinct from multimorbidity. Multimorbidity describes the presence of multiple chronic conditions. A person can live with several well-controlled diseases and remain relatively robust, while another person with fewer diagnoses may be highly vulnerable to stress. Similarly, frailty is not the same as disability. Disability describes difficulty performing activities; frailty describes vulnerability and reduced reserve. The two often overlap, particularly when frailty becomes more advanced, but a person may be frail before becoming dependent in basic activities of daily living.
Sarcopenia is also related but distinct. Loss of muscle strength and mass can contribute substantially to physical frailty, but frailty may reflect a wider combination of physiological and functional vulnerabilities. These distinctions matter because a useful frailty assessment should add information that chronological age, a disease list or a disability assessment alone does not provide.
Why frailty matters for quality and patient safety
Frailty changes how risk is experienced. A medication that causes mild dizziness in a robust person may contribute to a serious fall in someone with limited reserve. Several days of bed rest may cause little lasting change in one patient but major deconditioning in another. A routine hospital-to-home transition may become unsafe when mobility, cognition, medication burden and caregiver capacity are already fragile.
This is why frailty belongs within conversations about quality, patient safety and care planning, not only within specialist geriatric medicine. Recognizing frailty may prompt a team to look more carefully at baseline function, medication burden, delirium risk, mobility, nutrition, rehabilitation needs, caregiver readiness and the likely consequences of hospitalization or another physiological stressor.
Frailty should not, however, become a shortcut for restricting treatment. A major review in The New England Journal of Medicine emphasizes that frailty assessment can help clinicians tailor care and decisions about stressful treatments, but frailty thresholds are estimates rather than rigid rules. Clinical decisions still need to consider the person’s context, goals and preferences.
The relevant question is therefore not “Is this person too frail for treatment?” It is “How does this person’s vulnerability change the likely benefits, harms, support needs and recovery pathway that we need to plan for?”
New evidence from Viet Nam makes this discussion increasingly relevant
Evidence from Viet Nam is becoming much more informative.
A prospective cohort study published in September 2026 followed 1,208 community-dwelling people aged 60 years and older in Binh Thanh District, Ho Chi Minh City for 12 months using the Clinical Frailty Scale, or CFS. At baseline, 59.9% were classified as robust, 7.8% as vulnerable, 31.2% as having mild-to-moderate frailty and 1.2% as having severe frailty. During follow-up, 23.6% experienced at least one of the composite outcomes of death, a fall or hospitalization. The composite event rate rose progressively from 9.7% among robust participants to 29.8% among those classified as vulnerable, 47.2% among those with mild-to-moderate frailty and 64.3% in the small severe-frailty group. Each one-point increase in CFS remained independently associated with higher odds of an adverse outcome after adjustment for demographic and clinical factors.
These findings provide valuable prospective evidence from a Vietnamese community setting, but they should not be treated as a national frailty prevalence estimate. The study involved a defined urban population, used one frailty instrument and included only 14 participants in the severe-frailty category. Its stronger contribution is showing that frailty severity provided meaningful prognostic information within this Vietnamese cohort beyond several conventional clinical variables.
A 2026 study of 305 older patients with atrial fibrillation in Viet Nam provides another important lesson. Frailty prevalence was 34.4% using a modified physical frailty phenotype. Using the study’s CFS ≥4 threshold, 87.5% were classified as frail, and agreement between the two approaches was poor, with a kappa of 0.14. CFS-defined frailty was associated with hospitalization during nine months of follow-up, while the association using the modified physical phenotype was weaker and did not reach statistical significance after adjustment.
The difference between 34.4% and 87.5% illustrates why frailty prevalence cannot be interpreted without knowing the instrument and cutoff. In the conventional CFS categorization, a score of 4 is generally described as vulnerable, while the study deliberately used CFS ≥4 as its frailty definition. Results using that threshold should therefore not be compared casually with studies using CFS ≥5 or a different frailty construct.
A further prospective study involving 379 older adults with cancer at two Vietnamese hospitals found a frailty prevalence of 26.6% using the Carolina Frailty Index. Frailty was strongly associated with falls and short-term mortality. Its association with hospitalization was present in simpler models but became less certain after additional adjustment for cancer stage.
Together, these Vietnamese studies point in the same general direction while also offering a warning: frailty can identify clinically meaningful vulnerability, but how frailty is defined and measured matters greatly.
There is no single frailty tool for every purpose
The frailty field includes many instruments: the Fried physical frailty phenotype, Clinical Frailty Scale, deficit-accumulation Frailty Index, FRAIL scale, Edmonton Frail Scale, electronic Frailty Index, Hospital Frailty Risk Score and several specialty-specific tools.
An updated review published in the February 2026 issue of the European Journal of Internal Medicine summarizes this diversity and emphasizes that different measures reflect different concepts and practical purposes.
The Fried phenotype focuses largely on physical characteristics such as weakness, slowness, exhaustion, low activity and weight loss. A deficit-accumulation Frailty Index constructs frailty from a broader collection of health deficits. The Clinical Frailty Scale uses an overall clinical judgment of fitness, function and vulnerability. Other tools prioritize speed, feasibility or particular specialties and settings.
The Vietnamese atrial-fibrillation study illustrates why this matters. Applying two recognized approaches to the same 305 participants produced very different proportions classified as frail. This does not mean that one instrument necessarily measured frailty “correctly” and the other did not. It shows that different approaches capture different aspects of vulnerability and should be selected according to the decision they are intended to support.
For a Vietnamese health care organization, the first question should therefore not be “Which frailty scale should we adopt?” It should be “What decision do we want frailty information to support, in which population and setting, and what will happen after vulnerability is identified?”
A rapid instrument suitable for acute care may not be the best approach for longitudinal community follow-up. A research instrument may be too burdensome for routine practice. A tool that depends on clinical judgment requires training and consistency if different professionals are expected to use it.
Screening is not the same as understanding why someone is frail
Identifying possible frailty and understanding the causes of a person’s vulnerability are different tasks.
International clinical guidance has generally treated a positive frailty screen as a reason for further assessment rather than as a complete diagnosis or treatment plan. More comprehensive assessment can identify potentially modifiable contributors involving nutrition, medication, mobility, psychological health, medical conditions and social circumstances.
Two people with the same frailty score may therefore require very different responses. One person may have become vulnerable after inactivity, weight loss and a poorly tolerated medication regimen. Another may have advanced multimorbidity and progressive functional decline. Their likely trajectories, priorities and realistic care goals may differ substantially.
A frailty result is best understood as information that opens the door to more individualized care, not as the final answer. This is also why measuring only the proportion of older people screened for frailty would tell us relatively little about quality. What matters is whether recognizing vulnerability changed assessment, decisions, intervention or follow-up.
Frailty and intrinsic capacity overlap, but they are not the same concept
This distinction is particularly important in Viet Nam because the Ministry of Health’s new home- and community-care guidance is built partly around WHO’s Integrated Care for Older People, or ICOPE, approach.
WHO uses intrinsic capacity to describe the combination of an individual’s physical and mental capacities. ICOPE 2nd edition assesses domains including cognition, mobility, vitality, vision, hearing and psychological capacity and links identified declines with more detailed assessment, personalized care planning, implementation and monitoring.
Frailty and intrinsic capacity are closely related, but they organize the problem differently. Frailty focuses particularly on vulnerability and reduced reserve in the face of stressors, while intrinsic capacity focuses on the physical and mental capacities available to the person. Both approaches help move care beyond diagnosis lists toward function and the whole person, but they are not interchangeable.
This matters operationally in Viet Nam. Decision No. 1976/QĐ-BYT, issued on 1 July 2026, incorporates initial ICOPE-based intrinsic-capacity screening into professional guidance for older-person care at home and in the community. Trained commune health-station personnel, population collaborators, village health workers, social workers and volunteers can perform initial screening, with results linked back to the commune health station for assessment of identified decline, care needs and subsequent action.
Decision 1976 does not establish a national frailty-screening program or mandate one frailty instrument. If Vietnamese organizations begin incorporating frailty assessment, a coherent approach would be to determine where frailty information adds value to existing ICOPE and geriatric assessment pathways rather than creating another disconnected form or parallel program.
Frailty recognition can change hospital care and care transitions
Hospitalization itself can be a major physiological and functional stressor for someone with limited reserve. Acute illness may be accompanied by bed rest, disrupted sleep, medication changes, poor nutritional intake, delirium and loss of normal routines. Even when the condition that caused admission is successfully treated, an older person can leave hospital less mobile or independent than before.
Recognizing frailty can therefore affect several parts of routine hospital care. Teams may need to establish the person’s pre-admission functional baseline more carefully, minimize unnecessary immobilization and potentially harmful medicines, recognize delirium promptly, protect nutrition, involve rehabilitation earlier and start discharge planning with a clearer understanding of what the person and caregiver will need afterward.
Frailty also needs to be interpreted against the person’s usual baseline, particularly during acute illness. Temporary dependence during severe infection, for example, should not automatically be assumed to represent the person’s baseline frailty.
The same information can make transitions more risk-informed. Someone may meet conventional medical discharge criteria while still being poorly prepared for what happens next. Frailty may signal a need to look more closely at changed mobility, cognition, medication complexity, rehabilitation access and caregiver capacity.
That does not mean frailty should automatically lead to longer hospitalization, institutional care or more intensive services. Its role is to support risk-informed planning, not predetermined disposition.
Frailty should inform treatment decisions, not replace them
Frailty becomes particularly relevant when an intervention itself imposes substantial physiological stress, as can occur with surgery, cancer therapy or complex cardiovascular treatment.
Chronological age alone provides limited information about how well a person may tolerate and recover from that stress. Frailty can add information about reserve, vulnerability and likely recovery needs, but it should contribute to shared decision-making rather than dictate it.
The Vietnamese oncology study provides a useful example. Frailty was strongly associated with falls and mortality during short-term follow-up, but the appropriate conclusion is not that frail older people should automatically receive less cancer treatment. Frailty information may instead prompt more careful assessment of functional reserve, nutrition, medication burden, likely treatment toxicity, rehabilitation needs, family support and the person’s priorities.
The broader evidence supports the same approach. The NEJM review emphasizes the use of frailty to tailor care and stressful treatment decisions rather than using score cutoffs as rigid rules.
Frailty should improve the quality of the decision, not make the decision on behalf of the person.
Frailty can change over time, but recognition alone is not an intervention
Frailty should not always be viewed as a fixed and inevitably progressive state. Some contributors to vulnerability may be modifiable, particularly earlier in the trajectory, although the potential for improvement differs substantially among individuals.
Clinical guidance supports approaches such as multicomponent physical activity, including resistance exercise, appropriate nutritional intervention, medication review and attention to treatable contributors. The response should follow the underlying problems identified rather than the frailty label alone.
Just as importantly, recognizing frailty does not itself improve outcomes.
A systematic review and meta-analysis published in its 2026 journal issue included 12 studies involving 6,819 community-dwelling older adults with frailty. Integrated-care interventions improved frailty measures and functional ability, but statistically significant benefits were not demonstrated for hospitalization, nursing-home admission, quality of life or mortality. All included studies came from high-income regions, which limits direct transferability to Viet Nam.
Another 2026 systematic review examining quality of life among community-dwelling older adults with frailty found no consistent overall improvement and considerable heterogeneity between interventions and settings.
The implementation lesson is important. Frailty recognition can identify who might need a different pathway, but whether outcomes improve depends on what happens next, which services are available, whether the intervention fits the person and how reliably it is delivered.
A frailty label can cause harm if it is used badly
Language can influence expectations. Calling someone “frail” may unintentionally lead professionals or families to expect inevitable decline, discourage activity, narrow treatment options or make decisions on the person’s behalf. The person may also experience the term as a judgment about weakness or dependency.
The 2026 CIBERFES consensus specifically identifies stigma and misunderstanding around frailty as issues that require attention.
Frailty is therefore better communicated as clinical information about vulnerability and reserve, not as an identity. Rather than stopping at “this patient is frail,” a more useful conversation asks what the finding means: Is recovery likely to be slower? Which stressors pose greater risk? Which factors may be modifiable? What function matters most to the person? What support is needed?
Frailty is not the whole person. Someone can live with frailty while still having clear goals, meaningful relationships, preferences, strengths and substantial capacity in areas of life that matter to them.
Good care uses frailty information to understand vulnerability while continuing to see the person.
What could a practical frailty pathway look like in Viet Nam?
Viet Nam does not need to begin with a nationwide frailty-screening program. A more useful starting point would be to test frailty recognition in settings where the result is likely to change a real clinical or care decision.
A hospital might begin with older people admitted to a medical or surgical service where frailty could influence functional protection, rehabilitation or discharge planning. An outpatient service might focus on people with recent functional decline, repeated falls, multimorbidity or frequent acute-care use. A hospital-to-home program might use frailty alongside other factors to identify people who may benefit from more intensive transitional support.
Before introducing routine assessment, four questions should be clear. First, what decision is frailty assessment intended to support? Is the purpose perioperative planning, discharge, medication review, rehabilitation, proactive community care or another defined decision? Second, which instrument fits that purpose and setting? The tool should be feasible for the workforce, appropriate to the population and used with clearly specified definitions and thresholds.
Third, what happens when vulnerability is identified? The pathway may involve broader geriatric assessment, medication review, nutritional or mobility intervention, rehabilitation, caregiver assessment, shared decision-making or closer follow-up. The exact response should depend on the problems identified. Fourth, how will the organization know whether assessment helped? Completion rates alone are not enough. Useful measures might include whether identified problems were acted upon, functional change, falls, hospitalization, experience of care, caregiver readiness and implementation feasibility.
Frailty assessment should therefore be designed as part of a care pathway, not as another isolated score in the medical record.
Viet Nam has an opportunity to connect frailty with wider older-person care reform
The timing is useful because several parts of Viet Nam’s older-person care system are evolving at the same time.
ICOPE-based intrinsic-capacity screening is now included in Ministry of Health guidance for home and community care. Vietnamese researchers are generating prospective evidence on frailty in community, cardiovascular and oncology populations. At the same time, health policy is expanding geriatric services, community care and support outside hospitals.
Frailty could add value to that developing architecture if it answers questions that existing information does not already answer. It may help organizations recognize people whose apparent medical stability hides limited reserve, anticipate who may have difficulty recovering from a stressor, tailor treatment and rehabilitation, plan safer transitions and communicate vulnerability across settings.
But adding a frailty score without changing care would simply create more data.
The value of recognizing frailty is therefore not the label itself. It is whether recognizing vulnerability changes what the health and care system does next.
For Viet Nam, the most useful question is not “Should every older person be screened for frailty?” It is “Where would recognizing frailty improve a clinical or care decision, and can the system reliably respond once that vulnerability is identified?”
That is the question that connects frailty with quality, patient safety and practical care planning.
References
World Health Organization. WHO Clinical Consortium on Healthy Ageing: Topic Focus — Frailty and Intrinsic Capacity. WHO; 2017.
Álvarez-Bustos A, Andres-Lacueva C, Ara I, et al.; CIBERFES Working Group. Consensus document on frailty: conceptualization, detection, multidisciplinary management and future roadmap. Journal of Nutrition, Health and Aging. 2026;30(3):100793. PubMed Central (PMC)
Kim DH, Rockwood K. Frailty in Older Adults. New England Journal of Medicine. 2024;391(6):538–548. PubMed
Dent E, Hanlon P, Kowal P, Hoogendijk EO. Frailty measurement in research and clinical practice: An updated review. European Journal of Internal Medicine. 2026;144:106595. Epub 20 November 2025. PubMed
Trinh HBT, To KG, Nguyen TV. Clinical Frailty Scale and 12-month adverse health outcomes among community-dwelling older adults in Vietnam: a prospective cohort study. Frontiers in Medicine. 2026;13:1910694. Frontiers
Nguyen TV, Nguyen HQ, Chen L, et al. Frailty in older patients with atrial fibrillation in Vietnam: a comparison between the physical frailty phenotype and the Clinical Frailty Scale. BMC Geriatrics. 2026;26:509. Springer Link
Nguyen TV, Tran QHH, Amsalu E, et al. Frailty in older patients with cancer in Vietnam. BMC Geriatrics. 2026;26:1007. Springer Link
Dent E, Morley JE, Cruz-Jentoft AJ, et al. Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management. Journal of Nutrition, Health and Aging. 2019;23(9):771–787. PubMed
World Health Organization. Integrated Care for Older People (ICOPE): Guidance for Person-Centred Assessment and Pathways in Primary Care. 2nd ed. Geneva: WHO; 2025. World Health Organization
Ministry of Health of Viet Nam. Decision No. 1976/QĐ-BYT issuing professional guidance on care for older people at home and in the community. 1 July 2026. THƯ VIỆN PHÁP LUẬT
Yu J, Si H, Zhou W, et al. Effectiveness, Process, and Economic Outcomes of Integrated Care for Community-Dwelling Frail Older Adults: A Systematic Review and Meta-Analysis. Journal of Advanced Nursing. 2026;82(6):6894–6915. PubMed
Boyce J, Patton D, Watson C, et al. The impact of integrated care on quality of life in community-dwelling older adults with frailty: A systematic review and mixed method synthesis. Journal of Frailty & Aging. 2026;15(3):100150.